PCI Announces Definitive Agreement to Acquire Penn Pharma
PR Newswire Association LLC |
Penn Pharma's drug development, manufacturing, and packaging services complement PCI's own growth in Clinical Trial and Commercial supply services, having expanded both its global operations in
"We are very excited about adding Penn Pharma's expertise and experience in drug development," states
PCI is principally owned by
About Penn Pharma
As one of the longest established pharmaceutical services companies, Penn Pharma has 30 years of experience in providing integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry. Penn Pharma is privately owned and operates from a single site facility in
About PCI
The global healthcare industry trusts PCI for the packaging solutions that increase their products' speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global packaging needs throughout the product life cycle — from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients' lives. For more information please visit www.pciservices.com or follow us on Twitter at @PCI_Social.
About
Founded in 1991,
About
Established in 2000 as a global venture capital firm,
About QIC Private Equity
QIC Global Private Equity (QIC GPE) is a business unit of
About Thomas,
Thomas,
Contact
SOURCE
Wordcount: | 972 |
Ex-Cover Oregon Official Back To Help Fight Oracle
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News